We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App

Cutting-Edge Microcatheter Advances Localized Drug Delivery in Vascular Interventions

By HospiMedica International staff writers
Posted on 01 Mar 2024
Print article
Image: The Embolx Soldier High Flow Microcatheter has received US FDA clearance (Photo courtesy of Embolx)
Image: The Embolx Soldier High Flow Microcatheter has received US FDA clearance (Photo courtesy of Embolx)

A cutting-edge microcatheter allows for easy navigation through small complex vascular structures, providing enhanced reach to distal target sites.

Embolx Inc. (Sunnyvale, CA, USA) has introduced the Soldier High Flow Microcatheter, a new advancement in localized drug delivery for vascular interventions. This microcatheter is engineered using the Ultra-Thin Wall (UTW) technology and advanced design principles, which were originally developed for Embolx’s Sniper, the company's flagship product. The UTW technology is a key feature that allows the microcatheters to have a smaller outer diameter while maintaining the largest possible internal lumens. This design significantly enhances flow rates, almost doubling them compared to standard designs. The Soldier microcatheter stands out for its ability to combine the benefits of larger catheters into a profile. This development means that physicians no longer need to compromise on image quality, the ability to reach distal areas, or the range of embolic agents when using a smaller 2 Fr catheter.

Notably, the catheter's design ensures excellent torque response and features a radiopaque distal tip. These characteristics facilitate precise placement of the curved tip and enable clear visualization of its rotational position during procedures. The Soldier microcatheter is set to be available in two sizes: 2 Fr and 2.5 Fr. It also comes in three different lengths – 130 cm, 155 cm, and 165 cm – to accommodate various procedural needs. The 2 Fr version features a 0.022” lumen, while the 2.5 Fr version has a 0.027” lumen. This range of options underscores the versatility of the Soldier microcatheter in different clinical settings. The U.S. Food and Drug Administration (FDA) has granted clearance for the Soldier High Flow Microcatheter, allowing Embolx to refine the overall experience of physicians using microcatheters while creating an innovative platform for future products.

"The FDA clearance of the Soldier microcatheter represents a significant milestone in the evolution of advanced microcatheters. With this cutting-edge technology, it is now possible to use smaller microcatheters for more embolization procedures," said Michael Allen, CEO and President of Embolx. "We will continue to develop innovative and unique products that provide creative solutions to therapy delivery."


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Solid State Kv/Dose Multi-Sensor
Silver Member
Wireless Mobile ECG Recorder
Ceiling-Mounted Digital Radiography System
Radiography 5000 C

Print article


Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.